156 related articles for article (PubMed ID: 24115432)
21. [BCL11A represses HbF expression and varies during ontogeny].
Labie D
Med Sci (Paris); 2009 May; 25(5):457-60. PubMed ID: 19480825
[No Abstract] [Full Text] [Related]
22. Recent advances in globin research using genome-wide association studies and gene editing.
Orkin SH
Ann N Y Acad Sci; 2016 Mar; 1368(1):5-10. PubMed ID: 26866328
[TBL] [Abstract][Full Text] [Related]
23. The E3 ligase adaptor molecule SPOP regulates fetal hemoglobin levels in adult erythroid cells.
Lan X; Khandros E; Huang P; Peslak SA; Bhardwaj SK; Grevet JD; Abdulmalik O; Wang H; Keller CA; Giardine B; Baeza J; Duffner ER; El Demerdash O; Wu XS; Vakoc CR; Garcia BA; Hardison RC; Shi J; Blobel GA
Blood Adv; 2019 May; 3(10):1586-1597. PubMed ID: 31126914
[TBL] [Abstract][Full Text] [Related]
24. Highly efficient therapeutic gene editing of human hematopoietic stem cells.
Wu Y; Zeng J; Roscoe BP; Liu P; Yao Q; Lazzarotto CR; Clement K; Cole MA; Luk K; Baricordi C; Shen AH; Ren C; Esrick EB; Manis JP; Dorfman DM; Williams DA; Biffi A; Brugnara C; Biasco L; Brendel C; Pinello L; Tsai SQ; Wolfe SA; Bauer DE
Nat Med; 2019 May; 25(5):776-783. PubMed ID: 30911135
[TBL] [Abstract][Full Text] [Related]
25. Cytokine-mediated increases in fetal hemoglobin are associated with globin gene histone modification and transcription factor reprogramming.
Sripichai O; Kiefer CM; Bhanu NV; Tanno T; Noh SJ; Goh SH; Russell JE; Rognerud CL; Ou CN; Oneal PA; Meier ER; Gantt NM; Byrnes C; Lee YT; Dean A; Miller JL
Blood; 2009 Sep; 114(11):2299-306. PubMed ID: 19597182
[TBL] [Abstract][Full Text] [Related]
26. BCL11A enhancer dissection by Cas9-mediated in situ saturating mutagenesis.
Canver MC; Smith EC; Sher F; Pinello L; Sanjana NE; Shalem O; Chen DD; Schupp PG; Vinjamur DS; Garcia SP; Luc S; Kurita R; Nakamura Y; Fujiwara Y; Maeda T; Yuan GC; Zhang F; Orkin SH; Bauer DE
Nature; 2015 Nov; 527(7577):192-7. PubMed ID: 26375006
[TBL] [Abstract][Full Text] [Related]
27. Direct Promoter Repression by BCL11A Controls the Fetal to Adult Hemoglobin Switch.
Liu N; Hargreaves VV; Zhu Q; Kurland JV; Hong J; Kim W; Sher F; Macias-Trevino C; Rogers JM; Kurita R; Nakamura Y; Yuan GC; Bauer DE; Xu J; Bulyk ML; Orkin SH
Cell; 2018 Apr; 173(2):430-442.e17. PubMed ID: 29606353
[TBL] [Abstract][Full Text] [Related]
28. Mi2β-mediated silencing of the fetal γ-globin gene in adult erythroid cells.
Amaya M; Desai M; Gnanapragasam MN; Wang SZ; Zu Zhu S; Williams DC; Ginder GD
Blood; 2013 Apr; 121(17):3493-501. PubMed ID: 23444401
[TBL] [Abstract][Full Text] [Related]
29. Control of developmentally primed erythroid genes by combinatorial co-repressor actions.
Stadhouders R; Cico A; Stephen T; Thongjuea S; Kolovos P; Baymaz HI; Yu X; Demmers J; Bezstarosti K; Maas A; Barroca V; Kockx C; Ozgur Z; van Ijcken W; Arcangeli ML; Andrieu-Soler C; Lenhard B; Grosveld F; Soler E
Nat Commun; 2015 Nov; 6():8893. PubMed ID: 26593974
[TBL] [Abstract][Full Text] [Related]
30. Hemoglobin switching's surprise: the versatile transcription factor BCL11A is a master repressor of fetal hemoglobin.
Bauer DE; Orkin SH
Curr Opin Genet Dev; 2015 Aug; 33():62-70. PubMed ID: 26375765
[TBL] [Abstract][Full Text] [Related]
31. [BCL11A controls the expression of the human fetal hemoglobin].
Labie D
Med Sci (Paris); 2012 Nov; 28(11):923-5. PubMed ID: 23171892
[No Abstract] [Full Text] [Related]
32. Hemoglobin genetics: recent contributions of GWAS and gene editing.
Smith EC; Orkin SH
Hum Mol Genet; 2016 Oct; 25(R2):R99-R105. PubMed ID: 27340226
[TBL] [Abstract][Full Text] [Related]
33. Pharmacologic manipulation of fetal hemoglobin in the hemoglobinopathies.
Nathan DG
Ann N Y Acad Sci; 1990; 612():179-83. PubMed ID: 1705406
[No Abstract] [Full Text] [Related]
34. miRNA-embedded shRNAs for Lineage-specific BCL11A Knockdown and Hemoglobin F Induction.
Guda S; Brendel C; Renella R; Du P; Bauer DE; Canver MC; Grenier JK; Grimson AW; Kamran SC; Thornton J; de Boer H; Root DE; Milsom MD; Orkin SH; Gregory RI; Williams DA
Mol Ther; 2015 Sep; 23(9):1465-74. PubMed ID: 26080908
[TBL] [Abstract][Full Text] [Related]
35. Targeted deletion of BCL11A gene by CRISPR-Cas9 system for fetal hemoglobin reactivation: A promising approach for gene therapy of beta thalassemia disease.
Khosravi MA; Abbasalipour M; Concordet JP; Berg JV; Zeinali S; Arashkia A; Azadmanesh K; Buch T; Karimipoor M
Eur J Pharmacol; 2019 Jul; 854():398-405. PubMed ID: 31039344
[TBL] [Abstract][Full Text] [Related]
36. Identification of novel mutations in the HbF repressor gene BCL11A in patients with autism and intelligence disabilities.
Cai T; Chen X; Li J; Xiang B; Yang L; Liu Y; Chen Q; He Z; Sun K; Liu PP
Am J Hematol; 2017 Dec; 92(12):E653-E656. PubMed ID: 28891213
[No Abstract] [Full Text] [Related]
37. 2p15-p16.1 microdeletions encompassing and proximal to BCL11A are associated with elevated HbF in addition to neurologic impairment.
Funnell AP; Prontera P; Ottaviani V; Piccione M; Giambona A; Maggio A; Ciaffoni F; Stehling-Sun S; Marra M; Masiello F; Varricchio L; Stamatoyannopoulos JA; Migliaccio AR; Papayannopoulou T
Blood; 2015 Jul; 126(1):89-93. PubMed ID: 26019277
[TBL] [Abstract][Full Text] [Related]
38. Development and characterization of K562 cell clones expressing BCL11A-XL: Decreased hemoglobin production with fetal hemoglobin inducers and its rescue with mithramycin.
Finotti A; Gasparello J; Breveglieri G; Cosenza LC; Montagner G; Bresciani A; Altamura S; Bianchi N; Martini E; Gallerani E; Borgatti M; Gambari R
Exp Hematol; 2015 Dec; 43(12):1062-1071.e3. PubMed ID: 26342260
[TBL] [Abstract][Full Text] [Related]
39. HIC2 controls developmental hemoglobin switching by repressing BCL11A transcription.
Huang P; Peslak SA; Ren R; Khandros E; Qin K; Keller CA; Giardine B; Bell HW; Lan X; Sharma M; Horton JR; Abdulmalik O; Chou ST; Shi J; Crossley M; Hardison RC; Cheng X; Blobel GA
Nat Genet; 2022 Sep; 54(9):1417-1426. PubMed ID: 35941187
[TBL] [Abstract][Full Text] [Related]
40. Intermediaries of branched chain amino acid metabolism induce fetal hemoglobin, and repress SOX6 and BCL11A, in definitive erythroid cells.
Karkashon S; Raghupathy R; Bhatia H; Dutta A; Hess S; Higgs J; Tifft CJ; Little JA
Blood Cells Mol Dis; 2015 Aug; 55(2):161-7. PubMed ID: 26142333
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
